Aliases & Classifications for Pericarditis

MalaCards integrated aliases for Pericarditis:

Name: Pericarditis 12 54 43 15 62 17 71

Classifications:



External Ids:

Disease Ontology 12 DOID:1787
MeSH 43 D010493
NCIt 49 C34915
SNOMED-CT 67 3238004
ICD10 32 I32 I32.8
UMLS 71 C0031046

Summaries for Pericarditis

PubMed Health : 62 About pericarditis: Pericarditis (PER-ih-kar-DI-tis) is a condition in which the membrane, or sac, around your heart is inflamed. This sac is called the pericardium (per-ih-KAR-de-um). The pericardium holds the heart in place and helps it work properly. The sac is made of two thin layers of tissue that enclose your heart. Between the two layers is a small amount of fluid. This fluid keeps the layers from rubbing against each other and causing friction.

MalaCards based summary : Pericarditis is related to constrictive pericarditis and pericardial tuberculosis, and has symptoms including chest pain An important gene associated with Pericarditis is PRG4 (Proteoglycan 4), and among its related pathways/superpathways are Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. and Cytokine Signaling in Immune system. The drugs Oseltamivir and Coal tar have been mentioned in the context of this disorder. Affiliated tissues include heart, lung and liver, and related phenotypes are homeostasis/metabolism and growth/size/body region

Disease Ontology : 12 A pericardium disease that is characterized by an inflammation of the pericardium and has symptom chest pain.

Wikipedia : 74 Pericarditis is inflammation of the pericardium (the fibrous sac surrounding the heart). Symptoms... more...

Related Diseases for Pericarditis

Diseases related to Pericarditis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 1115)
# Related Disease Score Top Affiliating Genes
1 constrictive pericarditis 34.9 NPPB CRP ADA
2 pericardial tuberculosis 34.1 IFNG CRP ADA
3 idiopathic recurrent pericarditis 33.9 TNFRSF1A RETN MEFV LEP ADIPOQ
4 systemic onset juvenile idiopathic arthritis 33.1 TNF IL1B
5 drug reaction with eosinophilia and systemic symptoms 32.7 TNF CRP
6 juvenile rheumatoid arthritis 32.3 TNFRSF1A TNF IL6 IL1B IFNG CXCL8
7 cardiac tamponade 32.1 TNFRSF1A NPPB CRP ADA
8 pericardial effusion 32.0 TNFRSF1A NPPB IL6 CRP ADA
9 systemic lupus erythematosus 31.9 TNFRSF1A TNF IL6 IL1B IFNG CXCL8
10 myocarditis 31.3 TNF NPPB IL6 IL1B IFNG
11 haemophilus influenzae 31.3 TNF CXCL8
12 endocarditis 31.2 TNF IL6 IFNG CXCL8 CRP
13 congestive heart failure 31.2 TNNT2 TNF NPPB IL6 CRP
14 vasculitis 31.2 TNF MEFV IL6 CRP
15 enthesopathy 31.1 TNF MEFV CRP
16 acute myocardial infarction 31.1 TNNT2 NPPB IL6 CRP
17 mitral valve insufficiency 31.0 TNNT2 NPPB CRP
18 infective endocarditis 31.0 TNNT2 TNF IL6 CRP
19 cardiogenic shock 31.0 NPPB IL6 CRP
20 acute myocarditis 31.0 NPPB IL6 CRP
21 angina pectoris 30.9 NPPB IL6 CRP
22 q fever 30.9 TNF IL6 IL1B IFNG
23 collagen disease 30.8 TNF IL6 CRP
24 pulmonary tuberculosis 30.8 TNF IL6 IFNG CRP ADA
25 mycobacterium tuberculosis 1 30.8 TNFRSF1A TNF IFNG CRP ADA
26 chickenpox 30.8 TNF IL6 IFNG CRP ADA
27 colitis 30.8 TNF IL6 IL1B IFNG CXCL8
28 familial mediterranean fever 30.7 TNFRSF1A TNF MEFV IL6 IL1B CRP
29 pneumonia 30.7 TNF IL6 IL1B IFNG CXCL8 CRP
30 atrial fibrillation 30.7 TNNT2 NPPB IL6 CRP
31 rheumatic disease 30.7 TNF MEFV IL1B IFNG CRP
32 bronchopneumonia 30.7 TNF IL6 CXCL8 CRP
33 exanthem 30.7 TNF MEFV IL6 CXCL8 CRP
34 cardiac rupture 30.7 TNF CXCL8 CRP
35 uremia 30.7 TNF RETN LEP IL6 CRP
36 herpes zoster 30.7 TNF IFNG CRP
37 rheumatic fever 30.7 TNF NPPB IL6 IFNG
38 echinococcosis 30.7 TNF IL6 IFNG
39 arthropathy 30.7 TNF PRG4 IL6 IL1B IFNG CRP
40 sarcoidosis 1 30.7 TNF IL1B IFNG CRP ADA
41 rheumatic heart disease 30.6 TNF NPPB IL6 IL1B
42 melioidosis 30.6 TNF IL6 IFNG
43 polyarteritis nodosa 30.6 MEFV IL6 CRP
44 osteomyelitis 30.6 TNF IL6 IL1B IFNG CXCL8
45 purpura 30.6 TNF MEFV IL6 CRP
46 ulcerative colitis 30.6 TNF IL6 IL1B IFNG CXCL8 CRP
47 influenza 30.6 TNF IL6 IL1B IFNG CXCL8
48 heart valve disease 30.6 TNNT2 NPPB IL1B CRP
49 autoimmune disease 30.6 TNF IL6 IL1B IFNG CXCL8 CRP
50 aortitis 30.6 TNF IL6 CRP

Graphical network of the top 20 diseases related to Pericarditis:



Diseases related to Pericarditis

Symptoms & Phenotypes for Pericarditis

Symptoms:

12
  • chest pain

MGI Mouse Phenotypes related to Pericarditis:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10.25 ADA ADIPOQ CRP IFNG IL1B IL6
2 growth/size/body region MP:0005378 10.23 ADA ADIPOQ ENO2 IFNG IL1B IL6
3 cardiovascular system MP:0005385 10.22 ADA ADIPOQ CRP IFNG IL1B IL6
4 immune system MP:0005387 10.18 ADA ADIPOQ CRP IFNG IL1B IL6
5 hematopoietic system MP:0005397 10.17 ADA ADIPOQ IFNG IL1B IL6 IRAK4
6 integument MP:0010771 9.97 ADIPOQ IFNG IL1B IL6 LEP MEFV
7 liver/biliary system MP:0005370 9.91 ADA ADIPOQ IFNG IL6 LEP MEFV
8 muscle MP:0005369 9.76 ADA ADIPOQ IFNG IL6 LEP TNF
9 neoplasm MP:0002006 9.5 ADIPOQ IFNG IL1B IL6 LEP TNF
10 respiratory system MP:0005388 9.28 ADA ADIPOQ ENO2 IFNG IL6 LEP

Drugs & Therapeutics for Pericarditis

PubMed Health treatment related to Pericarditis: 62

Most cases of pericarditis are mild; they clear up on their own or with rest and simple treatment . Other times, more intense treatment is needed to prevent complications. Treatment may include medicines and, less often, procedures or surgery . The goals of treatment include: Reducing pain and inflammation Treating the underlying cause, if it's known Checking for complications

Drugs for Pericarditis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 78)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Oseltamivir Approved Phase 4 196618-13-0, 204255-11-8 65028
2
Coal tar Approved Phase 4 8007-45-2
3 Antiviral Agents Phase 4
4 Vaccines Phase 4
5 Antibodies Phase 4
6 Immunoglobulins Phase 4
7 Rho(D) Immune Globulin Phase 4
8 Immunoglobulins, Intravenous Phase 4
9 gamma-Globulins Phase 4
10
Methylprednisolone Approved, Vet_approved Phase 3 83-43-2 6741
11
Methylprednisolone hemisuccinate Approved Phase 3 2921-57-5
12
Prednisolone Approved, Vet_approved Phase 3 50-24-8 5755
13 Prednisolone acetate Approved, Vet_approved Phase 3 52-21-1
14
Prednisolone phosphate Approved, Vet_approved Phase 3 302-25-0
15
Streptokinase Approved, Investigational Phase 3 9002-01-1
16
Nitroglycerin Approved, Investigational Phase 3 55-63-0 4510
17
Rilonacept Approved, Investigational Phase 3 501081-76-1 104924
18
Bisoprolol Approved Phase 3 66722-44-9 2405
19
Ramipril Approved Phase 3 87333-19-5 5362129
20
Trastuzumab Approved, Investigational Phase 3 180288-69-1 9903
21
Prednisolone hemisuccinate Experimental Phase 3 2920-86-7
22 Antiemetics Phase 3
23 Methylprednisolone Acetate Phase 3
24 Gastrointestinal Agents Phase 3
25 Neuroprotective Agents Phase 3
26 Protective Agents Phase 3
27 Pharmaceutical Solutions Phase 3
28 Autonomic Agents Phase 3
29 Adrenergic beta-Antagonists Phase 3
30 Antihypertensive Agents Phase 3
31 HIV Protease Inhibitors Phase 3
32 Neurotransmitter Agents Phase 3
33
protease inhibitors Phase 3
34 Adrenergic Antagonists Phase 3
35 Adrenergic beta-1 Receptor Antagonists Phase 3
36 Adrenergic Agents Phase 3
37 Angiotensin-Converting Enzyme Inhibitors Phase 3
38 Sympatholytics Phase 3
39
Atorvastatin Approved Phase 2 134523-00-5 60823
40
Eplerenone Approved Phase 2 107724-20-9 150310 443872
41
Abatacept Approved Phase 2 332348-12-6 10237
42
Minocycline Approved, Investigational Phase 1, Phase 2 10118-90-8 5281021
43
Durvalumab Approved, Investigational Phase 1, Phase 2 1428935-60-7
44
Cyclophosphamide Approved, Investigational Phase 2 50-18-0, 6055-19-2 2907
45
Doxorubicin Approved, Investigational Phase 2 23214-92-8 31703
46
Vincristine Approved, Investigational Phase 2 2068-78-2, 57-22-7 5978
47
rituximab Approved Phase 2 174722-31-7 10201696
48
3,5-diiodothyropropionic acid Investigational Phase 1, Phase 2 1158-10-7
49 Hydroxymethylglutaryl-CoA Reductase Inhibitors Phase 2
50 Anti-Infective Agents Phase 1, Phase 2

Interventional clinical trials:

(show top 50) (show all 76)
# Name Status NCT ID Phase Drugs
1 Banlangen Granules Anti-seasonal Influenza Study: a Randomized, Double Blind, Positive and Placebo Controlled,Clinical Study. Unknown status NCT02232945 Phase 4 placebo of oseltamivir phosphate;oseltamivir phosphate;Banlangen (Radix Isatidis) granules;placebo of Banlangen(Radix Isatidis) granules
2 AnakInRa for Treatment of Recurrent Idiopathic Pericarditis Completed NCT02219828 Phase 4 Anakinra;Placebo
3 Treatment and Prevention of Pericarditis With Colchicine. A Multicenter Double Blind Randomized Trial. The CORP 2 Trial: COlchicine for Recurrent Pericarditis. Completed NCT00235079 Phase 4 Colchicine;Placebo
4 Cochicine Treatment for Post- Operative Pericardial Effusion: The POPE 2 Study A Multicenter, Double-blind, Randomized Trial Completed NCT01266694 Phase 4 Colchicines;Placebo
5 Vaccinia Vaccination (ACAM2000®) of Plasma Donors for the Production of Vaccinia Immune Globulin Intravenous (VIGIV) Recruiting NCT02443623 Phase 4
6 Anti-inflammatory Effects of Colchicine in Patients Undergoing Percutaneous Coronary Intervention: Inflammatory Marker Substudy of the Colchicine-PCI Trial Active, not recruiting NCT01709981 Phase 4 Colchicine;Placebo
7 Benign Acute Pericarditis: Brief Versus Longer Treatment. Randomized, Multicentric, Double Blind, Non Inferiority Trial Terminated NCT00946907 Phase 4 Aspirin;placebo
8 Myocardial Screening in Fetuses With Congenital Cytomegalovirus (CMV) Infection Unknown status NCT02787382 Phase 3
9 Treatment and Prevention of Pericarditis With Colchicine. A Multicenter Double Blind Randomized Trial. The ICAP Trial: Investigation on Colchicine for Acute Pericarditis Completed NCT00128453 Phase 3 Colchicine (for 3 months);Placebo
10 Treatment and Prevention of Pericarditis With Colchicine. A Multicenter Double Blind Randomized Trial. The CORP Trial: COlchicine for Recurrent Pericarditis Completed NCT00128414 Phase 3 Colchicine (for 6 months);Placebo
11 Treatment and Prevention of Pericarditis With Colchicine. A Multicenter Double Blind Randomized Trial. The COPPS Trial: COlchicine for the Prevention of Postpericardiotomy Syndrome Completed NCT00128427 Phase 3 Colchicine (for 1 month)
12 A Trial of Adjunctive Prednisolone and Mycobacterium w Immunotherapy in Tuberculous Pericarditis Completed NCT00810849 Phase 3 Prednisolone
13 Efficacy and Safety of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia Completed NCT01373281 Phase 3
14 A Prospective Phase III Parallel, Randomised Controlled Trial Using Double-bolus Recombinant Staphylokinase (THR-100) vs Streptokinase in Patients With Acute Myocardial Infarction Completed NCT01305226 Phase 3 THR-100;Streptokinase
15 Does Glyceryl Nitrate Prevent Post-Endoscopic Retrograde Cholangiopancreaticography (ERCP) Pancreatitis? Completed NCT00121901 Phase 3 glyceryl nitrate
16 Phase 3, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study With Open-label Extension, to Assess the Efficacy and Safety of Rilonacept Treatment in Subjects With Recurrent Pericarditis Recruiting NCT03737110 Phase 3 Rilonacept;Placebo
17 A Trial of Complete Percutaneous Pericardial Drainage Facilitated by Intrapericardial Alteplase Compared to Conventional Pericardiocentesis When Indicated in Adults With Large Pericardial Effusion Due to Tuberculous and Non-tuberculous Pericarditis Recruiting NCT02673879 Phase 3
18 Colchicine in Postoperative Fontan Patients (CPFP) Recruiting NCT03575572 Phase 2, Phase 3 Colchicine
19 Role of ACE Inhibitors and Beta Blockers as Cardiotoxicity Prevention in Breast Cancer Patients Treated With (Neo)Adjuvant Anthracyclines and/or Trastuzumab: a Four Arm, Placebo Control, Randomized Trial Recruiting NCT02236806 Phase 3 Bisoprolol;Ramipril;Placebo
20 Colchicine Versus Placebo in Post-Cardiac Surgery Patients to Prevent Post-Pericardiotomy Syndrome and Atrial Fibrillation Terminated NCT02177266 Phase 3 Colchicine;Placebo
21 A Randomized, Prospective Double Blind Placebo Control Clinical Trial of Prednisone as Adjunctive Therapy for the Treatment of Hospitalized Patients With Pulmonary TB and HIV Co-infection Withdrawn NCT00414414 Phase 3 Prednisone;placebo
22 An Open-Label Pilot Study of KPL-914 in Recurrent Pericarditis Completed NCT03980522 Phase 2 KPL-914
23 Interest of COLchicine in the Treatment of Patients With Acute Myocardial INfarction and With Inflammatory Response Completed NCT02363725 Phase 2 Colchimax®;Conventional treatment
24 A Phase IIB, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept vs Placebo on a Background of Oral Glucocorticosteroids in the Treatment of Subjects With Systemic Lupus Erythematosus and the Prevention of Subsequent Lupus Flares Completed NCT00119678 Phase 2 Abatacept;Placebo;Prednisone;Abatacept
25 A Randomized Comparison of Radiation Therapy Techniques in the Management of Node Positive Breast Cancer Completed NCT00581256 Phase 1, Phase 2
26 Randomized, Double-Blind, Placebo-Controlled Trial if IL1-TRAP, Rilonacept, in Systemic Sclerosis -A Phase I/II Biomarker Trial Completed NCT01538719 Phase 1, Phase 2 Rilonacept
27 A Randomised, Double Blind Pilot Study of Minocycline and Placebo Added to Treatment-as-Usual (TAU) in First-Episode Psychosis Completed NCT00916461 Phase 1, Phase 2 Minocycline;Placebo
28 A Phase I/II Trial of Stereotactic Body Radiation Therapy (SBRT) Dose Escalation in the Treatment of Patients With Inoperable Stage I/II Non-Small Cell Lung Cancer Arising Within the Zone of the Proximal Bronchial Tree Completed NCT00591838 Phase 1, Phase 2
29 Treatment of Acute Pericarditis With Anakinra Recruiting NCT03224585 Phase 2 Anakinra;Placebo
30 Randomized Phase I/II Study of Ablative Radiotherapy +/- MEDI 4736 (Durvalumab) for Medically Inoperable Early-Stage Non-Small Cell Lung Cancer Recruiting NCT03148327 Phase 1, Phase 2 Durvalumab (MEDI 4736)
31 Phase II, Randomised, Multicentre Study With Two Treatment Arms (R-COMP Versus R-CHOP) in Newly Diagnosed Elderly Patients (≥60 Years) With Non-localised Diffuse Large B-cell Lymphoma (DLBCL)/Follicular Lymphoma Grade IIIb. Active, not recruiting NCT02012088 Phase 2 RCOMP;RCHOP
32 A Randomized, Double-Blind Placebo-Controlled Study of 3,5-diiodothyropropionic Acid (DITPA) in Combination With Standard Therapy to Attain NCEP ATP III Goal for LDL Cholesterol in Hypercholesterolemic Patients Terminated NCT00311987 Phase 1, Phase 2 3,5-Diiodothyropropionic acid (DITPA) therapy
33 Dose-Ranging, Safety And Efficacy Of Cathflo(TM) Activase(R) (Alteplase) For The Treatment Of Central Catheter Occlusion In Neonates And Infants; Phase I Terminated NCT00265005 Phase 1 alteplase
34 Phase 1 Study to Assess the Safety of 500mg of Aspirin Added to IV TPA at Standard Doses to Prevent Re-occlusion of Cerebral Vessels After Successful Reperfusion. Withdrawn NCT00417898 Phase 1 Aspirin
35 Clinical Audit of the Management of Pericarditis in Children. Unknown status NCT03253315
36 Improvement of the Etiological Diagnosis of the Pericarditis Unknown status NCT02828085
37 Noise of Airplanes a Factor of Risk for the Health of the Heart in Pilots and Crew in Operations of the F16 Airplane Unknown status NCT01063582
38 Safety of a Early Discharge Strategy in Patients With Low-risk ST-segment Elevation Myocardial Infarction Treated With Primary Coronary Intervention: a Randomized Controlled Trial Unknown status NCT01868256
39 Transient ECG Changes in Patients With Acute Biliary Disease Unknown status NCT01706068
40 A Randomised Controlled Trial of Oxygen Therapy in Acute Myocardial Infarction (AVOID - Air Verses Oxygen In myocarDial Infarction Study) Unknown status NCT01272713
41 ST Elevation (Acute Coronary Syndrome Versus Pericarditis;Could Measurement of Lp-associated PLA2 -a Vascular Specific Marker of Inflammation- be Helpful to the Clinician? Completed NCT01041339
42 ACAM2000® Myopericarditis Registry Completed NCT01395082
43 A Phase IV Enhanced Safety Surveillance Study of ACAM2000® in Military Personnel Completed NCT00927719
44 A Translational Study to Understand the Mechanism of Apolipoprotein CIII Reduction Via Colchicine Completed NCT02083510 Early Phase 1 Colchicine
45 Epipericardial Fat Necrosis: A Misdiagnosed Condition Completed NCT01903980
46 Retrospective Review of Cardiomyopathy Patient Cases Post Allogeneic Hematopoietic Stem Cell Transplantation Completed NCT00352209
47 HIV-HEART STUDY: A Prospective, Epidemiologic and Multicentre Trial to Determine the Cardiovascular Risk in HIV-infected Patients Completed NCT01667068
48 Prospective Ⅱ Study of Stereotactic Body Radiation Therapy for Thymoma and Thymic Carcinoma: Therapeutic Effect and Toxicity Assessment Completed NCT03078699
49 HIV-HEART STUDY: A Prospective, Epidemiologic and Multicentre Trial to Determine the Cardiovascular Risk in HIV-infected Patients Completed NCT01196273
50 AIDS-Associated Heart Disease -- Incidence and Etiology Completed NCT00005228

Search NIH Clinical Center for Pericarditis

Cochrane evidence based reviews: pericarditis

Genetic Tests for Pericarditis

Anatomical Context for Pericarditis

MalaCards organs/tissues related to Pericarditis:

40
Heart, Lung, Liver, Bone, Kidney, Breast, Thyroid

Publications for Pericarditis

Articles related to Pericarditis:

(show top 50) (show all 11314)
# Title Authors PMID Year
1
Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome. 54 61
20074469 2009
2
Tuberculous pericarditis. 54 61
16330703 2005
3
Adenosine deaminase activity--more than a diagnostic tool in tuberculous pericarditis. 54 61
16049586 2005
4
Idiopathic recurrent acute pericarditis: familial Mediterranean fever mutations and disease evolution in a large cohort of Caucasian patients. 54 61
16218464 2005
5
The role of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) evaluation in pericardial fluid for the recognition of malignant pericarditis. 54 61
9479590 1997
6
Pathology of radiation induced heart disease. 61
32021573 2020
7
Aymé-Gripp Syndrome 61
32027476 2020
8
Successful treatment of complicated pericarditis after myocardial infarction with interleukin-1 blocker. 61
31359060 2020
9
A case of recurrent constrictive pericarditis induced by pericardial substitution with an expanded polytetrafluoroethylene membrane. 61
32008186 2020
10
Protection against avian pathogenic Escherichia coli and Salmonella Kentucky exhibited in chickens given both probiotics and live Salmonella vaccine. 61
32029160 2020
11
CMR for Identifying the Substrate of Ventricular Arrhythmia in Patients With Normal Echocardiography. 61
31326488 2020
12
Onset of idiopathic recurrent pericarditis during pregnancy: successful management with colchicine and intravenous immunoglobulins. 61
32040030 2020
13
Transcriptional analysis of RstA/RstB in avian pathogenic Escherichia coli identifies its role in the regulation of hdeD-mediated virulence and survival in chicken macrophages. 61
31928702 2020
14
Impact of Escherichia coli infection in broiler breeder chicks: The effect of oxidative stress on weight gain. 61
31715322 2020
15
Vitamin C Intravenous Treatment In the Setting of Atrial Fibrillation Ablation: Results From the Randomized, Double-Blinded, Placebo-Controlled CITRIS-AF Pilot Study. 61
32013700 2020
16
Recurrent Pericarditis as an Initial Presentation of Rheumatoid Arthritis. 61
31421065 2020
17
Large left ventricular non-infectious vegetation in patient with eosinophilic granulomatosis with polyangiitis. 61
31995113 2020
18
[Pericardial Fenestration and Multidisciplinary Treatment to Improve the Prognosis of the Malignant Pericarditis Due to Lung Cancer]. 61
31956251 2020
19
Cardiovascular disease in the Systemic Vasculitides. 61
32000652 2020
20
Myocardial injury and pericarditis after combined left atrial and coronary sinus ablation in Wolff-Parkinson-White syndrome: a case report. 61
31952491 2020
21
Heart failure enigma in young man: the acute onset of a frequently encountered condition with an unexpected cause. 61
31959653 2020
22
National trends of acute pericarditis post-atrial fibrillation ablation. 61
31602732 2020
23
[Adult-onset Still's disease complications]. 61
31924392 2020
24
Mycotic Coronary Aneurysms. 61
30686642 2020
25
Pseudonormalization of the Typical Electrocardiography Repolarization Pattern of a Black Athlete. 61
29944514 2020
26
Sensitivity analysis for the generalized shared-parameter model framework. 61
31246135 2020
27
Peculiarities of the Clinical Course of Chronic Viral Hepatitis C in the Background of End-Stage Chronic Renal Insufficiency. 61
32008494 2020
28
Usefulness of Cardiac Magnetic Resonance for Recurrent Pericarditis. 61
31711636 2020
29
Diagnosis and Management of Tuberculous Pericarditis: What Is New? 61
31940097 2020
30
Overlooked pericarditis complicated with cardiac tamponade due to an uncommon cause. 61
31504354 2020
31
Management of Acute and Recurrent Pericarditis: JACC State-of-the-Art Review. 61
31918837 2020
32
Percutaneous Simple Lead Traction Is a Feasible and Effective Method for Right Ventricular Lead Perforations. 61
31956147 2020
33
Salmonella typhimurium myopericarditis: A case report and review of literature. 61
31984129 2020
34
Pediatric Pericarditis Case Report. 61
31831113 2020
35
Purulent pericarditis: subdiaphragmatic suppurative focus. 61
31661755 2020
36
Acute pericarditis: Update on diagnosis and management. 61
31941732 2020
37
Managing acute and recurrent idiopathic pericarditis. 61
31880644 2020
38
Diagnostic performance of interferon-gamma release assay for diagnosis of tuberculous pericarditis: A meta-analysis. 61
31927772 2020
39
Management of Acute Idiopathic (Viral) Pericarditis in the Emergency Department: A Review for the Nursing Professional. 61
32000187 2020
40
Management of Acute Idiopathic (Viral) Pericarditis in the Emergency Department: A Review for the Nursing Professional. 61
32000188 2020
41
Excision of visceral pericardium for chronic effusive constrictive pericarditis. 61
31480850 2020
42
Constrictive pericarditis as late complication of cryoballoon pulmonary vein isolation. 61
31956500 2020
43
Pericardiectomy for constrictive pericarditis: a risk factor analysis for early and late failure. 61
31236676 2020
44
Impacts of Escherichia coli infection in young breeder chicks on the animal behavior and cerebral activity of purinergic and cholinergic enzymes involved in the regulation of molecules with neurotransmitter and neuromodulator function. 61
31604153 2020
45
Clinical characteristics and survival of 413 patients with systemic lupus erythematosus in southeastern areas of South Korea: A multicenter retrospective cohort study. 61
31802639 2020
46
Pericardial diseases in patients with cancer: contemporary prevalence, management and outcomes. 61
31980441 2020
47
Liver abscess with hiccups, and the potential association with pericarditis and colorectal cancer. 61
31926015 2020
48
Anaphylaxis-induced atrial fibrillation and anesthesia: Pathophysiologic and therapeutic considerations. 61
31929239 2020
49
Imaging of Acute Renal Failure in the Hospital Setting. 61
31731903 2020
50
Hemodynamics of constrictive pericarditis and restrictive cardiomyopathy. 61
31904891 2020

Variations for Pericarditis

Expression for Pericarditis

Search GEO for disease gene expression data for Pericarditis.

Pathways for Pericarditis

Pathways related to Pericarditis according to GeneCards Suite gene sharing:

(show top 50) (show all 70)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.6 TNFRSF1A TNF NPPB LEP IL6 IL1B
2
Show member pathways
13.39 TNFRSF1A TNF IRAK4 IL6 IL1B IFNG
3
Show member pathways
13.16 TNFRSF1A TNF IRAK4 IL6 IL1B IFNG
4
Show member pathways
12.98 TNFRSF1A TNF IRAK4 IL6 IL1B CXCL8
5
Show member pathways
12.88 TNF IL6 IL1B IFNG CXCL8
6
Show member pathways
12.87 TNFRSF1A TNF IRAK4 IL6 IL1B IFNG
7 12.84 TNFRSF1A TNF IRAK4 IL6 IL1B IFNG
8
Show member pathways
12.82 TNFRSF1A TNF RETN LEP IL6 ADIPOQ
9
Show member pathways
12.79 TNF IL6 IL1B IFNG CXCL8
10
Show member pathways
12.74 TNFRSF1A TNF IRAK4 IL6 IL1B
11
Show member pathways
12.71 TRAF3IP2 TNFRSF1A TNF IL1B IFNG
12 12.61 TNFRSF1A TNF IRAK4 IL1B IFNG
13 12.41 TNFRSF1A TNF IL1B CXCL8
14
Show member pathways
12.39 TNF IL6 IL1B IFNG CRP
15
Show member pathways
12.37 TNF IRAK4 IL6 IL1B IFNG CXCL8
16
Show member pathways
12.37 TRAF3IP2 TNF IL6 IL1B IFNG CXCL8
17
Show member pathways
12.36 TNFRSF1A TNF IL6 CXCL8
19
Show member pathways
12.32 TNFRSF1A TNF IRAK4 IL1B IFNG
20
Show member pathways
12.31 TNF IL6 IL1B IFNG CXCL8
21 12.31 TNFRSF1A TNF IRAK4 IL6 IL1B CXCL8
22
Show member pathways
12.3 TNF IRAK4 IL6 CXCL8
23
Show member pathways
12.28 TNF IRAK4 IL6 IL1B CXCL8
24
Show member pathways
12.26 TNFRSF1A TNF IL1B IFNG
25 12.23 TNFRSF1A TNF IL6 IFNG
26 12.23 TNF MEFV IRAK4 IL6 IL1B CXCL8
27 12.22 TNF IL6 IL1B CXCL8
28 12.21 TNFRSF1A TNF IRAK4 IL6 IL1B IFNG
29 12.14 TNFRSF1A TNF IL1B IFNG
30 12.12 TNF RETN LEP IL6 ADIPOQ
31
Show member pathways
12.11 TNF IL6 IL1B IFNG
32 12.1 TNFRSF1A TNF IL1B IFNG
33
Show member pathways
12.1 TNF IRAK4 IL6 IL1B IFNG CXCL8
34
Show member pathways
12.09 TNF IL6 IL1B IFNG
35 12.04 TNF IL6 IL1B CXCL8
36 12.03 TNFRSF1A TNF IL6 IL1B
37 12 IL6 IL1B IFNG CXCL8
38 11.98 TNFRSF1A TNF IRAK4 IL1B CXCL8
39 11.97 TNF IL6 IL1B IFNG CXCL8
40 11.96 TNF IL6 IL1B CXCL8
41 11.9 TNF IL6 IL1B IFNG CXCL8
42 11.86 IL6 IL1B IFNG CXCL8
43 11.83 IL6 IFNG CXCL8
44 11.82 TNF IL1B IFNG
45 11.82 TNF IL6 IL1B IFNG
46
Show member pathways
11.79 TNF IFNG CXCL8
47 11.79 TNF IL6 IL1B IFNG
48 11.78 TNFRSF1A TNF LEP ADIPOQ
49 11.77 TNFRSF1A TNF IRAK4
50 11.74 TNF IRAK4 IL6 IL1B CXCL8

GO Terms for Pericarditis

Cellular components related to Pericarditis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.77 TNFRSF1A TNF RETN PSG2 PRG4 NPPB
2 extracellular space GO:0005615 9.47 TNFRSF1A TNF RETN NPPB LEP IRAK4

Biological processes related to Pericarditis according to GeneCards Suite gene sharing:

(show all 42)
# Name GO ID Score Top Affiliating Genes
1 immune response GO:0006955 10.08 TNF PRG4 IL6 IL1B IFNG CXCL8
2 positive regulation of gene expression GO:0010628 10.07 TNF IL6 IL1B IFNG CRP
3 positive regulation of protein phosphorylation GO:0001934 9.94 TNF IL1B IFNG ADIPOQ
4 cellular response to lipopolysaccharide GO:0071222 9.94 TNF IL6 IL1B CXCL8
5 negative regulation of inflammatory response GO:0050728 9.91 TNFRSF1A MEFV ADIPOQ ADA
6 cytokine-mediated signaling pathway GO:0019221 9.88 TNFRSF1A TNF IRAK4 IL6 IL1B CXCL8
7 inflammatory response GO:0006954 9.87 TNFRSF1A TNF MEFV IL6 IL1B CXCL8
8 response to glucocorticoid GO:0051384 9.85 TNF IL6 ADIPOQ
9 glucose metabolic process GO:0006006 9.84 TNF LEP ADIPOQ
10 positive regulation of T cell proliferation GO:0042102 9.83 LEP IL6 IL1B
11 positive regulation of interleukin-6 production GO:0032755 9.83 TNF IL6 IL1B
12 positive regulation of smooth muscle cell proliferation GO:0048661 9.83 TNF IRAK4 IL6
13 negative regulation of fat cell differentiation GO:0045599 9.81 TNF IL6 ADIPOQ
14 positive regulation of phagocytosis GO:0050766 9.8 TNF IL1B IFNG
15 regulation of insulin secretion GO:0050796 9.8 TNF LEP IL1B IFNG
16 positive regulation of nitric oxide biosynthetic process GO:0045429 9.79 TNF IL1B IFNG
17 positive regulation of JAK-STAT cascade GO:0046427 9.77 TNF LEP IL6
18 negative regulation of neurogenesis GO:0050768 9.76 TNF IL6 IL1B
19 humoral immune response GO:0006959 9.76 TRAF3IP2 TNF IL6 IFNG
20 positive regulation of interleukin-8 production GO:0032757 9.75 TNF IL1B ADIPOQ
21 positive regulation of I-kappaB kinase/NF-kappaB signaling GO:0043123 9.73 TRAF3IP2 TNFRSF1A TNF IRAK4 IL1B ADIPOQ
22 positive regulation of glial cell proliferation GO:0060252 9.72 TNF IL6 IL1B
23 embryonic digestive tract development GO:0048566 9.71 TNF CXCL8 ADA
24 astrocyte activation GO:0048143 9.7 TNF IL1B IFNG
25 positive regulation of ceramide biosynthetic process GO:2000304 9.69 TNFRSF1A TNF
26 positive regulation of membrane protein ectodomain proteolysis GO:0051044 9.69 TNF IL1B IFNG
27 negative regulation of amyloid-beta clearance GO:1900222 9.68 TNF IFNG
28 negative regulation of synaptic transmission GO:0050805 9.68 IL1B ADIPOQ
29 response to vitamin E GO:0033197 9.68 LEP ADA
30 death-inducing signaling complex assembly GO:0071550 9.67 TNFRSF1A TNF
31 neutrophil mediated immunity GO:0002446 9.67 IRAK4 IL6
32 interleukin-6 production GO:0032635 9.65 LEP IL1B
33 positive regulation of neuroinflammatory response GO:0150078 9.65 TNF IL6 IL1B
34 positive regulation of fever generation GO:0031622 9.63 TNF IL1B
35 sequestering of triglyceride GO:0030730 9.61 TNF IL1B
36 positive regulation of chemokine biosynthetic process GO:0045080 9.61 TNF IL1B IFNG
37 positive regulation of vitamin D biosynthetic process GO:0060557 9.57 TNF IFNG
38 positive regulation of nitrogen compound metabolic process GO:0051173 9.56 TNF IFNG
39 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.55 TNFRSF1A TNF LEP IL6 IFNG
40 regulation of establishment of endothelial barrier GO:1903140 9.54 TNFRSF1A TNF IL1B
41 positive regulation of calcidiol 1-monooxygenase activity GO:0060559 9.13 TNF IL1B IFNG
42 negative regulation of lipid storage GO:0010888 8.92 TNF LEP IL6 CRP

Molecular functions related to Pericarditis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 hormone activity GO:0005179 9.26 RETN NPPB LEP ADIPOQ
2 cytokine activity GO:0005125 9.1 TNF IL6 IL1B IFNG CXCL8 ADIPOQ

Sources for Pericarditis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....